Volume 4, Issue 8: Highlights from the European Association for the Study of the Liver (EASL) Meeting April 2016

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with HepatitisIt provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 4, Issue 8)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Describe effects of HCV resistance-associated variants on treatment outcomes.
  • Discuss treating HCV/HIV coinfections using direct-acting antivirals.
  • Discuss curing HCV in patients who failed previous treatments, including DAAs.
  • Discuss individualized salvage therapy based on RAV analysis.
  • Identify new DAA combinations to cure GT3 in infected patients.

 

Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
05/26/2016
Course expires: 
05/25/2018
Cost:
$0.00
Raymond T. Chung, MD
Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
 
Stephanie Petrou Binder, MD
Medical Writer
Berlin, Germany
 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
05/26/2016
Course expires: 
05/25/2018

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE